abstract |
The present invention provides a crystalline form of a specific compound and a method for treating a disease (for example, diseases of the central nervous system) using a pharmaceutical composition containing the compound. A crystalline form B of compound 1 represented by the formula and a pharmaceutical composition comprising the same. [Selection figure] None |